Limited Competition for the Data Coordinating Center of Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01)

Quick Facts

Due DateJuly 18, 2014 (Friday)
Award AmountUp to $ 2,500,000
Category of Funding ActivityFood and Nutrition
Health
Eligible Applicants
  • Others - Other Eligible Applicants include the following: Only the current awardee serving as the Data Coordinating Center of Multiethnic Study of Type 2 Diabetes Genes consortium (T2D-GENES) is eligible to apply for this Funding Opportunity Announcement. Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Program Description

This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator current awardee of the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Data Coordinating Center (DCC) (AMP T2D-GENES DCC). The AMP T2D-GENES consortium will consist of the DCC as well as participating sites being solicited by the companion FOA. The mission of AMP T2D-GENES is to characterize the genetic variations in human genomic regions that have been putatively associated with type 2 diabetes (T2D) and conduct follow-up functional studies of particular genetic variants. This is a one-time FOA to provide funds to the AMP T2D-GENES DCC to continue the development of the web portal and deposit, aggregate and process the data generated, as part of an ongoing consortium of AMP T2D-GENES investigators as well as T2D-GENES community, for a maximum of five years, contingent on satisfactory performance. To support the conduct of these studies, AMP T2D-GENES DCC will coordinate manage and support the centers and provide the administrative infrastructure for the NIDDK-funded AMP T2D-GENES consortium. The AMP T2D-GENES DCC will build on and expand the previous work of the T2D GENES consortium.

General Information

Funding Opportunity NumberRFA-DK-14-503
Funding Opportunity TitleLimited Competition for the Data Coordinating Center of Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01)
Opportunity CategoryFood and Nutrition
Health
Funding Instrument TypeCooperative Agreement
Category ExplanationNot Available
Number of Awards1
Cost Sharing or Matching RequirementNo
Posted DateApril 25, 2014 (Friday)
Application Due DateJuly 18, 2014 (Friday)
Application Archive DateAugust 18, 2014 (Monday)
Total Program Funding$ 2,500,000
Award AmountUp to $ 2,500,000
CFDA Number
  • 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research
  • 000000

Eligible Applicants

  • Others - Other Eligible Applicants include the following: Only the current awardee serving as the Data Coordinating Center of Multiethnic Study of Type 2 Diabetes Genes consortium (T2D-GENES) is eligible to apply for this Funding Opportunity Announcement. Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Contact Information

Agency NameDepartment of Health and Human Services
Program Information Websitehttp://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-503.html
ContactOffice: National Institutes of Health
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Search Federal Grants

Application Due Date:
-